Noticias y Actividades de Tonix Pharmaceuticals
Presencia
Tonix Pharmaceuticals es una empresa que cotiza bajo el símbolo de cotización TNXP (US).
Ejecutivos
Ver el organigrama con sus 21 ejecutivos principales
Biografías más buscadas en Tonix Pharmaceuticals
- Seth Lederman, Co-Founder, Chairman and Chief Executive Officer
- Adeoye Olukotun, Director
- Carolyn Taylor, Director
Recientes movimientos de ejecutivos en Tonix Pharmaceuticals
- Siobhan Fogarty que ha sido Executive Vice President, Product Development, ha ascendido a Chief Technical Officer (noticia publicada el 5 de febrero de 2025).
- Gary Ainsworth, se ha incorporado a la empresa como Vice President of Market Access (noticia publicada el 10 de enero de 2025).
- Bradley Raudabaugh, se ha incorporado a la empresa como Vice President, Marketing (noticia publicada el 3 de diciembre de 2024).
Haga clic aquí para ver otros movimientos en Tonix Pharmaceuticals
Crear su alerta
para seguir los movimientos de los ejecutivos en Tonix Pharmaceuticals.
Farmacia
Tonix Pharmaceuticals tiene 1.833 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Eli Lilly (Estados Unidos).
Popular M&A news in Farmacia
- Imbria Pharmaceuticals acaba de anunciar una recaudación de fondos de 58 millones de dólares. (publicado el 10 de abril de 2025).
- Clario ha NRx Pharmaceuticals adquirido (publicado el 18 de marzo de 2025).
- Knight Therapeutics has announced the acquisition of Paladin Labs (publicado el 12 de marzo de 2025).
Otros contactos sugeridos en el sector Farmacia
Noticias
Últimos comunicados de prensa de Tonix Pharmaceuticals
- Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies
- Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
- Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition
- Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference
- Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
- Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
- Press Releases
- Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate
- Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
- Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target
- View more press releases Close
Redes sociales sobre Tonix Pharmaceuticals
- Tonix Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
- Tonix Pharmaceuticals en LinkedIn, Twitter y YouTube
